12:00 AM
 | 
Mar 04, 2013
 |  BC Week In Review  |  Financial News  |  Other Financial News

NanoViricides financial update

NanoViricides retired its remaining 1,826 shares of series C convertible preferred stock sold to Seaside 88 for $2 million,...

Read the full 74 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >